217 related articles for article (PubMed ID: 19234170)
1. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
Mailloux AW; Young MR
J Immunol; 2009 Mar; 182(5):2753-65. PubMed ID: 19234170
[TBL] [Abstract][Full Text] [Related]
2. NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.
Mailloux AW; Clark AM; Young MR
Int J Cancer; 2010 Dec; 127(11):2598-611. PubMed ID: 20198623
[TBL] [Abstract][Full Text] [Related]
3. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
4. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
Olkhanud PB; Baatar D; Bodogai M; Hakim F; Gress R; Anderson RL; Deng J; Xu M; Briest S; Biragyn A
Cancer Res; 2009 Jul; 69(14):5996-6004. PubMed ID: 19567680
[TBL] [Abstract][Full Text] [Related]
6. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
[TBL] [Abstract][Full Text] [Related]
7. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
8. Tumors induce the formation of suppressor endothelial cells in vivo.
Mulligan JK; Young MR
Cancer Immunol Immunother; 2010 Feb; 59(2):267-77. PubMed ID: 19669642
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.
Liao C; Xiao W; Zhu N; Liu Z; Yang J; Wang Y; Hong M
Int J Clin Exp Pathol; 2015; 8(3):2535-44. PubMed ID: 26045759
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic depletion of CCR8
Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
[TBL] [Abstract][Full Text] [Related]
12. Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer.
Schott AK; Pries R; Wollenberg B
Int J Mol Med; 2010 Jul; 26(1):67-75. PubMed ID: 20514424
[TBL] [Abstract][Full Text] [Related]
13. Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.
Mulligan JK; Lathers DM; Young MR
Cancer Immunol Immunother; 2008 Jul; 57(7):951-61. PubMed ID: 18058097
[TBL] [Abstract][Full Text] [Related]
14. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.
Chen X; Hamano R; Subleski JJ; Hurwitz AA; Howard OM; Oppenheim JJ
J Immunol; 2010 Jul; 185(1):174-82. PubMed ID: 20525892
[TBL] [Abstract][Full Text] [Related]
15. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
[TBL] [Abstract][Full Text] [Related]
17. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
18. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.
Chen X; Subleski JJ; Kopf H; Howard OM; Männel DN; Oppenheim JJ
J Immunol; 2008 May; 180(10):6467-71. PubMed ID: 18453563
[TBL] [Abstract][Full Text] [Related]
20. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]